Skip to Content

IDEX Corp

IEX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$635.00XpdxjndJyznqngdq

Idex Earnings: Strong Results Given Headwinds in Health and Science Technologies

Narrow-moat-rated Idex ended 2023 with a solid fourth quarter, as its full-year revenue of $3.3 billion and adjusted EPS of $8.22 both came in above our estimates of $3.2 billion and $8.16. After rolling our model forward one year, we’ve raised our fair value estimate to $219 from $215, which reflects our updated near-term outlook as well as time value of money.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of IEX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center